Oncologist 2020 Sep 4
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
Related Questions
Data is still lacking regarding a possible synergistic effect with radiation and TKI. Would you be concerned that this would cause more side effects t...
New comment by Radiation Oncologist at Memorial Sloan Kettering Cancer Center ( February 10, 2025)
To this point, an important question to ask is about competing risks. If this is a man with favorable intermediate-risk prostate cancer and metastatic RCC, does active surveil...